Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction].
出版信息
Int J Nanomedicine. 2022 May 23;17:2319-2320. doi: 10.2147/IJN.S375352. eCollection 2022.